Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$12.87
-2.83%
Mkt Cap $1.11B
Analyst Ratings
Buy
6
Hold
7
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
Implied Upside
+8.8%
Consensus $14.00 vs current $12.87
NASDAQ·Healthcare·Biotechnology
$12.87
-2.83%
Mkt Cap $1.11B
Buy
6
Hold
7
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
+8.8%
Consensus $14.00 vs current $12.87